| 25 May 2026 |
Boldenone Undecylenate (EQ) Raw |
7.0 |
100g |
102.4g |
+2.4% |
97.38% |
Lab A |
| 24 May 2026 |
Stanozolol (Winstrol) Raw |
8.6 |
1g |
0.9g |
-9.0% |
98.62% |
Lab E |
| 24 May 2026 |
BPC157 10mg + TB500 10mg Blend |
9.8 |
2mg |
2.1mg |
+3.7% |
95.24% |
Lab F |
| 24 May 2026 |
Cerebrolysin |
10.0 |
5mg |
4.5mg |
-10.6% |
99.00% |
Lab B |
| 24 May 2026 |
CJC-1295 With DAC |
10.0 |
10mg |
8.7mg |
-12.6% |
99.96% |
Lab B |
| 24 May 2026 |
Deca (Nandrolone Decanoate) |
4.4 |
250mg/ml |
234.9mg/ml |
-6.0% |
99.24% |
Lab F |
| 24 May 2026 |
PMK methyl glycidate CAS 1369021-80-6 |
10.0 |
100g |
98.0g |
-2.0% |
98.15% |
Lab C |
| 23 May 2026 |
DHB (1-Test Cyp) Oral |
10.0 |
50mg |
52.3mg |
+4.6% |
97.13% |
Lab A |
| 21 May 2026 |
GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg |
9.4 |
10mg |
12.1mg |
+20.9% |
96.96% |
Lab B |
| 19 May 2026 |
Primobolan Oral (Methenolone Acetate) |
9.9 |
50mg |
46.0mg |
-8.1% |
96.26% |
Lab E |
| 17 May 2026 |
ANPP (4-anilino-N-phenethylpiperidine) CAS 21409-26-7 |
10.0 |
500g |
438.1g |
-12.4% |
96.24% |
Lab G |
| 29 Jan 2026 |
CJC-1295 w/o DAC 10mg + IPA 10mg Blend |
8.6 |
15mg |
17.4mg |
+15.7% |
98.16% |
Lab G |
| 29 Jan 2026 |
CJC-1295 w/o DAC 5mg + IPA 5mg Blend |
10.0 |
50mg |
56.9mg |
+13.7% |
98.29% |
Lab D |
| 26 Jan 2026 |
Hyaluronic acid |
9.8 |
10mg |
9.2mg |
-8.2% |
98.33% |
Lab E |
| 19 Jan 2026 |
Anavar (Oxandrolone) Raw |
9.6 |
10g |
10.5g |
+5.1% |
98.26% |
Lab B |
| 19 Jan 2026 |
BPC-157 Capsule |
7.7 |
100mg |
111.3mg |
+11.3% |
98.24% |
Lab G |
| 7 Jan 2026 |
5-amino-1MQ |
6.5 |
10mg |
8.9mg |
-10.6% |
97.72% |
Lab D |
| 12 Dec 2025 |
SNAP-8 |
10.0 |
5mg |
5.1mg |
+1.1% |
99.97% |
Lab C |
| 23 Nov 2025 |
Dihexa |
9.7 |
20mg |
23.3mg |
+16.4% |
96.67% |
Lab A |
| 17 Nov 2025 |
Immunological Enhancement (Glutathione 200mg+Ascorbic Acid 200mg+Zinc Sulfate 2.5mg) |
9.0 |
250mg/ml |
229.3mg/ml |
-8.3% |
97.22% |
Lab C |
| 17 Nov 2025 |
Lipo Mino Mix (B6+Methionine+Inositol+Choline+B1+B2+Carnitine) |
10.0 |
300mg/ml |
266.5mg/ml |
-11.2% |
96.09% |
Lab A |
| 17 Nov 2025 |
Retatrutide 5mg + Cagrilintide 5mg Blend |
7.9 |
5mg |
6.1mg |
+22.8% |
95.46% |
Lab C |
| 17 Nov 2025 |
Selank |
10.0 |
15mg |
18.7mg |
+24.5% |
96.71% |
Lab D |
| 5 Nov 2025 |
Tesofensine |
9.6 |
50mg |
61.0mg |
+22.0% |
95.96% |
Lab D |
| 4 Nov 2025 |
NA Selank Amidate |
8.5 |
20mg |
19.8mg |
-0.9% |
98.14% |
Lab B |
| 9 Oct 2025 |
GHK-CU 2000mcg+Glutathione 200mg+Histidine 100mg+Glycine 50mg+NADH 50mg |
8.9 |
200mg/ml |
173.2mg/ml |
-13.4% |
95.16% |
Lab G |
| 9 Oct 2025 |
GHRP-2 Acetate |
10.0 |
5mg |
6.2mg |
+24.8% |
98.10% |
Lab F |
| 9 Oct 2025 |
Test Enanthate |
8.3 |
100mg/ml |
100.3mg/ml |
+0.3% |
99.96% |
Lab B |
| 9 Oct 2025 |
Test Suspension |
9.1 |
200mg/ml |
185.0mg/ml |
-7.5% |
96.41% |
Lab E |
| 9 Oct 2025 |
Vilon |
5.8 |
2mg |
1.9mg |
-3.6% |
97.29% |
Lab F |
| 4 Sep 2025 |
Tirzepatide |
9.8 |
30mg |
28.3mg |
-5.7% |
99.95% |
Lab E |
| 4 Sep 2025 |
Tirzepatide |
10.0 |
40mg |
38.9mg |
-2.8% |
99.93% |
Lab E |
| 4 Sep 2025 |
Retatrutide |
10.0 |
5mg |
4.8mg |
-4.0% |
99.95% |
Lab E |
| 4 Sep 2025 |
Retatrutide |
9.8 |
20mg |
19.5mg |
-2.5% |
99.83% |
Lab E |
| 4 Sep 2025 |
Tirzepatide |
10.0 |
10mg |
9.75mg |
-2.5% |
99.90% |
Lab E |
| 1 Sep 2025 |
Tirzepatide |
8.4 |
20mg |
22.07mg |
+10.3% |
99.93% |
Lab A |
| 1 Sep 2025 |
Retatrutide |
6.0 |
10mg |
11.12mg |
+11.2% |
98.83% |
Lab A |